首页> 外文OA文献 >Synthese neuartiger Verbundwerkstoffe für den Knochenersatz aus Calciumphosphaten, Calciumcarbonaten und Polylactiden und deren mechanische und biologische Eigenschaften
【2h】

Synthese neuartiger Verbundwerkstoffe für den Knochenersatz aus Calciumphosphaten, Calciumcarbonaten und Polylactiden und deren mechanische und biologische Eigenschaften

机译:由磷酸钙,碳酸钙和聚丙交酯合成新型骨替代复合材料及其力学和生物学性能

摘要

Biodegradable composite materials consisting of polylactide (PDLLA and PLLA), β-tricalcium phosphate (β-TCP), and calcium carbonate were developed as a novel bone substitute candidate aiming to manufacture 3D scaffolds via selective laser melting (SLM). Polylactide was chosen as a biodegradable, meltable and adhesive component. β-TCP was used because of its bone-like mineral phase, calcium carbonate for buffering the acidic degradation of the polylactide component. Critical aspects were a vast volumetric swelling and an accelerated degradation of the polymeric component during the SLM process. Concerning to processing, mechanical strength and bone-like properties the polymeric content was set to 60 wt%. The prepared test specimens indicated a bending strength up to 90 MPa. Because of a vast volumetric swelling the bending strength of PDLLA-containing specimens decreased about 60 vol% after storage of 8 weeks in phosphate buffer. A swelling and thus a volume increase could be critical, especially for using the tri-phase bone substitute compound as 3D scaffold with defined dimensions. The swelling of the specimens was almost completely prevented by using PLLA instead of PDLLA. The viability of human mesenchymal stem cells cultivated on PDLLA-based materials decreased due to the volumetric swelling, while the cells cultivated on PLLA-based materials indicated a good viability.
机译:由聚丙交酯(PDLLA和PLLA),β-磷酸三钙(β-TCP)和碳酸钙组成的可生物降解复合材料被开发为新型的骨替代候选物,旨在通过选择性激光熔化(SLM)制造3D支架。选择聚丙交酯作为可生物降解,可熔融和粘合的组分。使用β-TCP的原因是它的骨状矿相碳酸钙可缓冲聚乳酸成分的酸性降解。至关重要的方面是在SLM工艺过程中聚合物组分的体积膨胀大和加速降解。关于加工,机械强度和骨样性质,将聚合物含量设定为60重量%。制备的试样显示出高达90 MPa的弯曲强度。由于体积膨胀大,在磷酸盐缓冲液中储存8周后,含PDLLA的试样的弯曲强度降低了约60 vol%。肿胀并因此增加体积可能至关重要,尤其是对于使用三相骨替代化合物作为具有确定尺寸的3D支架而言。使用PLLA代替PDLLA可以几乎完全防止样品膨胀。由于体积膨胀,在基于PDLLA的材料上培养的人间充质干细胞的活力降低,而在基于PLLA的材料上培养的人间充质干细胞则显示出良好的活力。

著录项

  • 作者

    Abert Jessica;

  • 作者单位
  • 年度 2017
  • 总页数
  • 原文格式 PDF
  • 正文语种 ger
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号